Discipline of Endocrinology & Metabolism, Department of Internal Medicine, University of Sao Paulo Medical School, University of Sao Paulo, Sao Paulo 01246 903, Brazil.
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Endocr Rev. 2023 Mar 4;44(2):193-221. doi: 10.1210/endrev/bnac020.
The etiology of central precocious puberty (CPP) is multiple and heterogeneous, including congenital and acquired causes that can be associated with structural or functional brain alterations. All causes of CPP culminate in the premature pulsatile secretion of hypothalamic GnRH and, consequently, in the premature reactivation of hypothalamic-pituitary-gonadal axis. The activation of excitatory factors or suppression of inhibitory factors during childhood represent the 2 major mechanisms of CPP, revealing a delicate balance of these opposing neuronal pathways. Hypothalamic hamartoma (HH) is the most well-known congenital cause of CPP with central nervous system abnormalities. Several mechanisms by which hamartoma causes CPP have been proposed, including an anatomical connection to the anterior hypothalamus, autonomous neuroendocrine activity in GnRH neurons, trophic factors secreted by HH, and mechanical pressure applied to the hypothalamus. The importance of genetic and/or epigenetic factors in the underlying mechanisms of CPP has grown significantly in the last decade, as demonstrated by the evidence of genetic abnormalities in hypothalamic structural lesions (eg, hamartomas, gliomas), syndromic disorders associated with CPP (Temple, Prader-Willi, Silver-Russell, and Rett syndromes), and isolated CPP from monogenic defects (MKRN3 and DLK1 loss-of-function mutations). Genetic and epigenetic discoveries involving the etiology of CPP have had influence on the diagnosis and familial counseling providing bases for potential prevention of premature sexual development and new treatment targets in the future. Global preventive actions inducing healthy lifestyle habits and less exposure to endocrine-disrupting chemicals during the lifespan are desirable because they are potentially associated with CPP.
中枢性性早熟(CPP)的病因多种多样,包括先天性和后天性原因,这些原因可能与脑结构或功能改变有关。CPP 的所有病因最终都会导致下丘脑 GnRH 的过早脉冲分泌,并因此导致下丘脑-垂体-性腺轴的过早重新激活。儿童时期兴奋性因素的激活或抑制性因素的抑制代表 CPP 的 2 个主要机制,揭示了这些相反的神经元途径之间的微妙平衡。下丘脑错构瘤(HH)是中枢神经系统异常的 CPP 最知名的先天性病因。已经提出了 HH 导致 CPP 的几种机制,包括与前下丘脑的解剖连接、GnRH 神经元的自主神经内分泌活性、HH 分泌的营养因子以及对下丘脑施加的机械压力。在 CPP 的潜在机制中,遗传和/或表观遗传因素的重要性在过去十年中显著增加,这一点可以从下丘脑结构性病变(例如错构瘤、神经胶质瘤)中的遗传异常、与 CPP 相关的综合征(Temple、Prader-Willi、Silver-Russell 和 Rett 综合征)以及孤立性 CPP 从单基因缺陷(MKRN3 和 DLK1 功能丧失突变)中得到证明。涉及 CPP 病因的遗传和表观遗传发现对诊断和家族咨询产生了影响,为未来预防性早熟发育和新的治疗靶点提供了基础。在整个生命周期中,诱导健康的生活方式习惯和减少接触内分泌干扰化学物质的全球预防措施是可取的,因为它们可能与 CPP 有关。